抗生素抗藥性診斷市場：全球 2024-2030 年

全基因定序和多重就地檢驗的轉變正在透過提高速度、準確性和高通量來推動變革性成長。

抗菌藥物抗藥性是指細菌、病毒和真菌不再對抗生素敏感，是全球十大公共衛生威脅之一。當病原體獲得抗藥性時，它​​們就會變得無效，並可能導致引發敗血症的感染疾病，大大增加嚴重疾病、殘疾和死亡的風險。

本報告研究了人類健康抗菌素抗藥性（AMR）診斷市場。它分析表現型和分子測試的收益和預測預測、競爭格局，並確定提供 IVD 平台（包括儀器、消耗品和資訊學）的供應商（製造商）。醫院、診所、診斷實驗室和其他機構是主要的最終使用者。該報告還提供了北美、歐洲、亞太、中東和非洲以及拉丁美洲的區域預測。透過分析推動和抑制市場成長的因素並識別關鍵成長機會，我們幫助市場參與者和相關人員利用趨勢，最大限度地發揮其經濟潛力並維持價值。基準年為2024年，預測期間為2025-2030年。

目錄

成長機會：研究範圍

• 分析範圍
• 分割

成長環境：抗菌藥物抗藥性診斷市場的轉型

• 成長為何變得越來越艱難？
• 策略要務
• 三大策略要務對抗菌藥物抗藥性診斷產業的影響

AMR 診斷市場生態系統

• 競爭環境
• 主要競爭對手

AMR 診斷市場的成長要素

• 成長指標
• 成長動力
• 成長抑制因素
• 檢查預測
• 收益預測
• 產品收益預測
• 各地區收益預測
• 收益預測分析
• 價格趨勢及預測分析
• 收益分享
• 競爭矩陣 –產品系列分析
• 收益分佈分析

用於表現型檢測的生長促進要素

• 成長指標
• 收益預測
• 各地區收益預測
• 預測分析

用於分子檢測的生長促進要素

• 成長指標
• 收益預測
• 各地區收益預測
• 預測分析

成長機會

• 成長機會1：利用 WGS 推動分子偵測
• 成長機會二：多重 POCT
• 成長機會3：公私合營抗菌藥物管理

附錄與後續步驟

The Shift to Whole-genome Sequencing and Multiplex Point-of-care Testing is Driving Transformational Growth Due to Improved Speed, Accuracy, and High Throughput

This Frost & Sullivan report examines the antimicrobial resistance (AMR) diagnostics market in human health. AMR, characterized by bacteria, viruses, and fungi that no longer respond to antimicrobial medications, is one of the top ten global public health threats. When pathogens develop drug resistance, medications become ineffective, leading to infections that may trigger sepsis and significantly increase the risk of severe illness, disability, and death. Covering in vitro diagnostics (IVD) methods, this report includes phenotypic and molecular tests for revenue and forecast estimations. It analyzes the competitive environment, identifying vendors (manufacturers) offering IVD platforms, including instruments, consumables, and informatics. Hospitals, clinics, diagnostic labs, and others encompass key end-user verticals.

The analysis offers a region-wise forecast for North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America. The study analyzes the factors driving and restraining the growth of this market and identifies key growth opportunities to help market players and stakeholders build on trends, maximize economic potential, and sustain value. The base year is 2024, and the forecast period is from 2025 to 2030.

Table of Contents

Growth Opportunities: Research Scope

• Scope of Analysis
• Segmentation

Growth Environment: Transformation in the AMR Diagnostics Market

• Why is it Increasingly Difficult to Grow?
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on the AMR Diagnostics Industry

Ecosystem in the AMR Diagnostics Market

• Competitive Environment
• Key Competitors

Growth Generators in the AMR Diagnostics Market

• Growth Metrics
• Growth Drivers
• Growth Restraints
• Forecast Considerations
• Revenue Forecast
• Revenue Forecast by Product
• Revenue Forecast by Region
• Revenue Forecast Analysis
• Pricing Trends and Forecast Analysis
• Revenue Share
• Competitor Matrix-Product Portfolio Analysis
• Revenue Share Analysis

Growth Generators for Phenotypic Tests

• Growth Metrics
• Revenue Forecast
• Revenue Forecast by Region
• Forecast Analysis

Growth Generators for Molecular Tests

• Growth Metrics
• Revenue Forecast
• Revenue Forecast by Region
• Forecast Analysis

Growth Opportunity Universe

• Growth Opportunity 1: WGS Driving Molecular Tests
• Growth Opportunity 2: Multiplex POCT
• Growth Opportunity 3: Antimicrobial Stewardship Through Private-Public Partnerships

Appendix & Next Steps

• Benefits and Impacts of Growth Opportunities
• Next Steps
• List of Exhibits
• Legal Disclaimer